3-(2-Methylbenzo[d]thiazol-3-ium-3-yl)propane-1-sulfonate

Catalog No. :
ACGVCP427
CAS No. :
56405-37-9
Molecular Formula :
C11H13NO3S2
Molecular Weight :
271.36

IUPAC Name:3-(2-methylbenzo[d]thiazol-3-ium-3-yl)propane-1-sulfonate

3-(2-Methylbenzo[d]thiazol-3-ium-3-yl)propane-1-sulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2-Methylbenzo[d]thiazol-3-ium-3-yl)propane-1-sulfonate
IUPAC Name3-(2-methylbenzo[d]thiazol-3-ium-3-yl)propane-1-sulfonate
MDL No.MFCD00044132
Molecular FormulaC11H13NO3S2
Molecular Weight271.36
SMILESO=S(CCC[N+]1=C(C)SC2=CC=CC=C12)([O-])=O
InChI KeyXSEOLEIVLCYZQR-UHFFFAOYSA-N
Synonym2-METHYL-3-SULFOPROPYL BENZOTHIAZOLIUM INNER SALT;3-(2-METHYL-1,3-BENZOTHIAZOL-3-IUM-3-YL)PROPANE-1-SULFONATE;benzothiazolium,2-methyl-3-(3-sulfopropyl)-,hydroxide,innersalt;2-methyl-3-(3-sulphonatopropyl)benzothiazolium;2-METHYL-3-(3-SULFOPROPYL)BENZOTHIAZOLIUM BETAINE;2-Methyl-3-(3-sulfonatopropyl)benzothiazol-3-ium;2-Methyl-3-(gamma-sulfopropyl)benzothiazolium hydroxide inner salt;Benzothiazolium, 2-methyl-3-(3-sulfopropyl)-, inner salt
CAS No.56405-37-9

Synthetic Route by SureRoute

1. ACGVCP427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLVNB781 route compound structure diagram
    ACLVNB781120-75-2 In Stock
  2. Plus
  3. ACUAMT395 route compound structure diagram
    ACUAMT39555788-44-8 In Stock
  4. Then
  5. ACGVCP427 route product structure diagram
    ACGVCP42756405-37-9
Inquiry

2. ACGVCP427 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLVNB781 route compound structure diagram
    ACLVNB781120-75-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGVCP427 route product structure diagram
    ACGVCP42756405-37-9
Inquiry

Comments (0)